news
GeroScience review questions dietary nucleotide and NAD supplements for muscle loss
A systematic review in GeroScience evaluated 65 studies on dietary nucleotides and NAD+ precursors for age-related sarcopenia, finding that evidence relies overwhelmingly on cellular and rodent models. Human clinical trials remain remarkably scarce despite aggressive commercial marketing. It matters for anyone spending triple digits on longevity powders to preserve aging muscle mass.
A systematic review in GeroScience evaluated 65 studies on dietary nucleotides and NAD+ precursors for age-related sarcopenia, finding that evidence relies overwhelmingly on cellular and rodent models. Human clinical trials remain remarkably scarce despite aggressive commercial marketing. It matters for anyone spending triple digits on longevity powders to preserve aging muscle mass.
The architecture take
I track supplement trends closely, and longevity brands love to sell cellular renewal in a sachet. This review draws a hard line on what the science actually shows. After screening 1,763 papers down to 65 relevant studies, the authors found that the case for dietary nucleotides and NAD+ precursors reversing muscle loss lives almost entirely in mice and petri dishes. I used to think popping mitochondrial precursors might save me from future frailty if I skimped on training. I was wrong. Nucleotides participate in RNA synthesis and cellular stress responses, yet swallowing them does not magically trigger muscle protein synthesis or rebuild fast-twitch fibers in an aging human body. The gut metabolizes most dietary RNA and DNA before it ever reaches skeletal muscle. (Your liver takes the lion's share anyway.) If you want to protect your physical baseline past sixty, lift heavy barbells and eat enough leucine. High-ticket longevity supplements remain an expensive distraction until human clinical trials prove otherwise.